Global Mycoplasma Testing Market Growth (Status and Outlook) 2023-2029

Global Mycoplasma Testing Market Growth (Status and Outlook) 2023-2029

The major factors driving this market are the increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination.

LPI (LP Information)' newest research report, the “Mycoplasma Testing Industry Forecast” looks at past sales and reviews total world Mycoplasma Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Mycoplasma Testing sales for 2023 through 2029. With Mycoplasma Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mycoplasma Testing industry.

This Insight Report provides a comprehensive analysis of the global Mycoplasma Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mycoplasma Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mycoplasma Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mycoplasma Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mycoplasma Testing.

The global Mycoplasma Testing market size is projected to grow from US$ 473.5 million in 2022 to US$ 1028.7 million in 2029; it is expected to grow at a CAGR of 11.7% from 2023 to 2029.

The Asia region is estimated to grow at the fastest rate which can be attributed to the increasing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.

This report presents a comprehensive overview, market shares, and growth opportunities of Mycoplasma Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
PCR
ELSA
Enzymatic Methods
DNA Staining

Segmentation by application
Pharmaceuticals
Food And Beverage Testing
Biotechnology, Biomedical Drugs
Environmental Test
Academic Research Institute
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories International
Merck Kgaa
Lonza Group
Roche Diagnostics
SGS
Thermo Fisher Scientific
American Type Culture Collection
Biounique Testing Laboratories
Invivogen
Promocell
Biological Industries Israel Beit Haemek
Wuxi Apptec
Norgen Biotek

Please note: The report will take approximately 2 business days to prepare and deliver.